Bank of New York Mellon »

Ocuphire Pharma shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-06-30 $503k 123k 4.11
2023-03-31 $61k 16k 3.75

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Ocuphire Pharma

Caligan Partners
Adage Capital Partners GP
BIOS Capital Management
BlackRock
Balyasny Asset Management
Nantahala Capital Management
Vanguard Capital Management
Boxer Capital Management
Trails Edge Capital Partners
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Marshall Wace
ADAR1 Capital Management
Goldman Sachs Group
Woodline Partners

View all funds holding Ocuphire Pharma